Placebo-Controlled Trial Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency:

[1]  L. Phillips,et al.  The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults. , 2002, The Journal of clinical endocrinology and metabolism.

[2]  J. Svensson,et al.  Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. , 2003, The Journal of clinical endocrinology and metabolism.

[3]  R. Murray,et al.  The effect of long‐term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH‐deficient adults , 2002, Clinical endocrinology.

[4]  W. Isley.  Growth Hormone Therapy for Adults: Not Ready for Prime Time? , 2002, Annals of Internal Medicine.

[5]  P. Sönksen,et al.  Growth hormone replacement therapy for adults: into the new millennium. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[6]  M. Alpsten,et al.  A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. , 2001, The Journal of clinical endocrinology and metabolism.

[7]  N. Skakkebaek,et al.  Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. , 2000, The Journal of clinical endocrinology and metabolism.

[8]  C. Sweep,et al.  Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  D. Cook,et al.  Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  A. Juul.  Determination of Insulin-Like Growth Factor-I in the Monitoring of Growth Hormone Treatment with Respect to Efficacy of Treatment and Side Effects: Should Potential Risks of Cardiovascular Disease and Cancer Be Considered? , 1999, Hormone Research in Paediatrics.

[11]  Murray,et al.  Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults , 1999, Clinical endocrinology.

[12]  S. Ljunghall,et al.  Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. , 1999, The Journal of clinical endocrinology and metabolism.

[13]  J. Viikari,et al.  Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. , 1999, European journal of endocrinology.

[14]  G. Sassolas,et al.  Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  R. Clayton,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults* , 2022 .

[16]  F. Roelfsema,et al.  Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[17]  P. Kann,et al.  Effect of long‐term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH‐deficient adults , 1998, Clinical endocrinology.

[18]  J. Veldhuis,et al.  Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[19]  G. Johannsson,et al.  Influence of gender and gonadal steroids on responsiveness to growth hormone replacement therapy in adults with growth hormone deficiency. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[20]  C. Ohlsson,et al.  Growth hormone and bone. , 1998, Endocrine reviews.

[21]  L. Wilhelmsen,et al.  Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. , 1997, European journal of endocrinology.

[22]  L. Sjöström,et al.  Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. , 1996, The Journal of clinical endocrinology and metabolism.

[23]  R. Baxter,et al.  Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  I. Wiklund,et al.  Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. , 1995, The Journal of clinical endocrinology and metabolism.

[25]  D. Johnston,et al.  Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults * , 1995, Clinical endocrinology.

[26]  A. O’Sullivan,et al.  Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. , 1995, The Journal of clinical endocrinology and metabolism.

[27]  N. Skakkebaek,et al.  Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. , 1994, The Journal of clinical endocrinology and metabolism.

[28]  N. Skakkebaek,et al.  Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. , 1994, European journal of endocrinology.

[29]  H. de Boer,et al.  Serum lipid levels in growth hormone-deficient men. , 1994, Metabolism: clinical and experimental.

[30]  I. Wiklund,et al.  Decreased psychological well‐being in adult patients with growth hormone deficiency , 1994, Clinical endocrinology.

[31]  L. Wilhelmsen,et al.  Cardiovascular risk factors in adult patients with growth hormone deficiency. , 1993, Acta endocrinologica.

[32]  L. Lönn,et al.  Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. , 1993, The Journal of clinical endocrinology and metabolism.

[33]  H. de Boer,et al.  Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. , 1992, The Journal of clinical endocrinology and metabolism.

[34]  K. Light,et al.  Reactivity to stress and psychological adjustment in adults with pituitary insufficiency , 1992, Clinical endocrinology.

[35]  P. Deurenberg,et al.  Body composition in growth hormone-deficient adults. , 1992, The American journal of clinical nutrition.

[36]  R. Reitan.  Trail Making Test: Manual for Administration and Scoring , 1992 .

[37]  B. Bengtsson,et al.  Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.

[38]  P. Sönksen,et al.  Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. , 1990, Hormone research.

[39]  C. Wiles,et al.  Skeletal muscle performance in adults with growth hormone deficiency. , 1990, Hormone research.

[40]  O. Westphal,et al.  Quality of Life of Adults with Growth Hormone Deficiency: a Controlled Study , 1989, Acta paediatrica Scandinavica. Supplement.

[41]  J. Sallis,et al.  Physical activity assessment methodology in the Five-City Project. , 1985, American journal of epidemiology.

[42]  S P McKenna,et al.  The Nottingham Health Profile: subjective health status and medical consultations. , 1981, Social science & medicine. Part A, Medical sociology.

[43]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.